Reviva Pharmaceuticals Holdings, Inc.
RVPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26,792 | $18,997 | $46,397 | $59,997 |
| - Cash | $13,183 | $10,364 | $5,289 | $13,476 |
| + Debt | $0 | $113 | $224 | $458 |
| Enterprise Value | $13,609 | $8,747 | $41,332 | $46,979 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,005 | -$6,041 | -$6,416 | -$6,250 |
| % Margin | – | – | – | – |
| Net Income | -$4,011 | -$6,054 | -$6,433 | -$6,259 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.055 | -0.12 | -0.13 | -0.16 |
| % Growth | 54% | 7.7% | 18.8% | – |
| Operating Cash Flow | -$5,589 | -$5,013 | -$8,194 | -$9,100 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$5,589 | -$5,013 | -$8,194 | -$9,100 |